Extension of Time to File SOU

SYNTHEA

The MITRE Corporation

Request for Extension of Time to File a Statement of Use

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 87686582
LAW OFFICE ASSIGNED LAW OFFICE 101
MARK SECTION
MARK SYNTHEA (see, http://uspto.report/TM/87686582/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT SYNTHEA
OWNER SECTION (current)
NAME The MITRE Corporation
MAILING ADDRESS 7515 Colshire Drive
CITY McLean
STATE Virginia
ZIP/POSTAL CODE 22102-7508
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 202-371-2600
FAX 202-371-2540
OWNER SECTION (proposed)
NAME The MITRE Corporation
MAILING ADDRESS 7515 Colshire Drive
CITY McLean
STATE Virginia
ZIP/POSTAL CODE 22102-7508
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 202-371-2600
FAX 202-371-2540
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME TRACY-GENE G. DURKIN
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE tm@sternekessler.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) tdurkin@sternekessler.com; jshirk@sternekessler.com
CORRESPONDENCE INFORMATION (proposed)
NAME Tracy-Gene G. Durkin
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE tm@sternekessler.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) tdurkin@sternekessler.com; jshirk@sternekessler.com; tfrancis@sternekessler.com
DOCKET/REFERENCE NUMBER 2272.2290000
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 009
CURRENT IDENTIFICATION software program for generating synthetic patients and synthetic electronic patient healthcare records for use by the healthcare industry, for research and innovation purposes, and for educational purposes; software that simulates the lifespan of synthetic patients for use by the healthcare industry, for research and innovation purposes, and for educational purposes; software for modeling primary healthcare encounters, chronic conditions, and treatment protocols within a synthetic patient population for use by the healthcare industry, for research and innovation purposes, and for educational purposes; software for generating synthetic patients for modeling the effects of health policy on patient access, patient health outcomes, and health costs; software for simulating patients for modelling the effects of health policy on patient access, patient health outcomes, and health costs; software for simulating patients with models of disease progression and corresponding standards of care to produce risk-free, realistic, synthetic, healthcare records at scale; computer software programs in the nature of a synthetic patient population simulator used to generate synthetic patients and synthetic patient data; providing synthetic patient data and associated healthcare records for research, innovation, and educational purposes; software for generating synthetic patient data for research, innovation, and educational purposes; software for generating synthetic patient healthcare records for research, innovation, and educational purposes
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 042
CURRENT IDENTIFICATION Compiling data on synthetic patients and associated health records for research purposes in the field of medical science and medical consultancy
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 3
ONGOING EFFORT product or service research or development
ALLOWANCE MAIL DATE 10/30/2018
STATEMENT OF USE YES
PAYMENT SECTION
NUMBER OF CLASSES 2
SUBTOTAL AMOUNT [EXTENSION FEE] 250
TOTAL AMOUNT 250
SIGNATURE SECTION
SIGNATURE /Tracy Durkin/
SIGNATORY'S NAME Tracy-Gene G. Durkin
SIGNATORY'S POSITION Attorney of Record, Washington, DC Bar Member
DATE SIGNED 04/28/2020
SIGNATORY'S PHONE NUMBER 202-371-2600
FILING INFORMATION
SUBMIT DATE Tue Apr 28 15:24:20 ET 2020
TEAS STAMP USPTO/ESU-XX.XXX.XXX.XXX-
20200428152420509238-8768
6582-710f7e94338ee3fb9a89
57389f081d9185c7ca81d3ca8
b1beeb5148b114add056ae-CC
-24186744-202004281234068
53019



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: SYNTHEA (see, http://uspto.report/TM/87686582/mark.png)
SERIAL NUMBER: 87686582

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: The MITRE Corporation, having an address of
      7515 Colshire Drive
      McLean, Virginia 22102-7508
      United States
      Phone: 202-371-2600
      Fax: 202-371-2540
Proposed: The MITRE Corporation, having an address of
      7515 Colshire Drive
      McLean, Virginia 22102-7508
      United States
      Phone: 202-371-2600
      Fax: 202-371-2540
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 10/30/2018.

For International Class 009:
Current identification: software program for generating synthetic patients and synthetic electronic patient healthcare records for use by the healthcare industry, for research and innovation purposes, and for educational purposes; software that simulates the lifespan of synthetic patients for use by the healthcare industry, for research and innovation purposes, and for educational purposes; software for modeling primary healthcare encounters, chronic conditions, and treatment protocols within a synthetic patient population for use by the healthcare industry, for research and innovation purposes, and for educational purposes; software for generating synthetic patients for modeling the effects of health policy on patient access, patient health outcomes, and health costs; software for simulating patients for modelling the effects of health policy on patient access, patient health outcomes, and health costs; software for simulating patients with models of disease progression and corresponding standards of care to produce risk-free, realistic, synthetic, healthcare records at scale; computer software programs in the nature of a synthetic patient population simulator used to generate synthetic patients and synthetic patient data; providing synthetic patient data and associated healthcare records for research, innovation, and educational purposes; software for generating synthetic patient data for research, innovation, and educational purposes; software for generating synthetic patient healthcare records for research, innovation, and educational purposes

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 042:
Current identification: Compiling data on synthetic patients and associated health records for research purposes in the field of medical science and medical consultancy

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the third extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development

A Statement of Use has already been submitted or is being submitted along with the Extension request as evidence that applicant believes that it has made valid use of the mark in commerce.   If the USPTO finds the Statement of Use to be fatally defective, the applicant requests additional time to file an amended or substitute Statement of Use.

Correspondence Information (current):
      TRACY-GENE G. DURKIN
      PRIMARY EMAIL FOR CORRESPONDENCE: tm@sternekessler.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): tdurkin@sternekessler.com; jshirk@sternekessler.com

Correspondence Information (proposed):
      Tracy-Gene G. Durkin
      PRIMARY EMAIL FOR CORRESPONDENCE: tm@sternekessler.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): tdurkin@sternekessler.com; jshirk@sternekessler.com; tfrancis@sternekessler.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $250 will be submitted with the form, representing payment for 2 classes.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /Tracy Durkin/      Date Signed: 04/28/2020
Signatory's Name: Tracy-Gene G. Durkin
Signatory's Position: Attorney of Record, Washington, DC Bar Member
Signatory's Phone: 202-371-2600

RAM Sale Number: 87686582
RAM Accounting Date: 04/28/2020

Serial Number: 87686582
Internet Transmission Date: Tue Apr 28 15:24:20 ET 2020
TEAS Stamp: USPTO/ESU-XX.XXX.XXX.XXX-202004281524205
09238-87686582-710f7e94338ee3fb9a8957389
f081d9185c7ca81d3ca8b1beeb5148b114add056
ae-CC-24186744-20200428123406853019



Extension of Time to File SOU [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed